Cherikh WS - Search Results

1

A comparison of discharge immunosuppressive drug regimens in primary cadaveric kidney transplantation.

Cherikh WS, Myron Kauffman H, Maghirang J, Bleyer AJ, Johnson CP. Cherikh WS, et al. Transplantation. 2003 Aug 15;76(3):463-70. doi: 10.1097/01.TP.0000079839.38844.09. Transplantation. 2003. PMID: 12923430

2

Drug regimens affect cadaveric kidney graft survival.

Kauffman HM, Cherikh WS, Delmonico FL. Kauffman HM, et al. Among authors: cherikh ws. Transplant Proc. 2001 Feb-Mar;33(1-2):1029-30. doi: 10.1016/s0041-1345(00)02316-2. Transplant Proc. 2001. PMID: 11267176 No abstract available.

3

A comparison of the survival of shipped and locally transplanted cadaveric renal allografts.

Mange KC, Cherikh WS, Maghirang J, Bloom RD. Mange KC, et al. Among authors: cherikh ws. N Engl J Med. 2001 Oct 25;345(17):1237-42. doi: 10.1056/NEJMoa010793. N Engl J Med. 2001. PMID: 11680443 Free article.

4

Transplant tumor registry: donors with central nervous system tumors1.

Kauffman HM, McBride MA, Cherikh WS, Spain PC, Delmonico FL. Kauffman HM, et al. Among authors: cherikh ws. Transplantation. 2002 Feb 27;73(4):579-82. doi: 10.1097/00007890-200202270-00017. Transplantation. 2002. PMID: 11889434

5

Post-transplant renal function in the first year predicts long-term kidney transplant survival.

Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP. Hariharan S, et al. Among authors: cherikh ws. Kidney Int. 2002 Jul;62(1):311-8. doi: 10.1046/j.1523-1755.2002.00424.x. Kidney Int. 2002. PMID: 12081593 Free article.

6

Transplant tumor registry: donor related malignancies.

Myron Kauffman H, McBride MA, Cherikh WS, Spain PC, Marks WH, Roza AM. Myron Kauffman H, et al. Among authors: cherikh ws. Transplantation. 2002 Aug 15;74(3):358-62. doi: 10.1097/00007890-200208150-00011. Transplantation. 2002. PMID: 12177614

7

Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation.

Cherikh WS, Kauffman HM, McBride MA, Maghirang J, Swinnen LJ, Hanto DW. Cherikh WS, et al. Transplantation. 2003 Nov 15;76(9):1289-93. doi: 10.1097/01.TP.0000100826.58738.2B. Transplantation. 2003. PMID: 14627905

8

ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney.

Bryan CF, Cherikh WS, Cheng Y, Aeder MI, Muruve NA, Nelson PW, Shield CF 3rd, Warady BA, Winklhofer FT. Bryan CF, et al. Among authors: cherikh ws. Clin Transplant. 2004;18 Suppl 12:55-60. doi: 10.1111/j.1399-0012.2004.00219.x. Clin Transplant. 2004. PMID: 15217409

9

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies.

Kauffman HM, Cherikh WS, Cheng Y, Hanto DW, Kahan BD. Kauffman HM, et al. Among authors: cherikh ws. Transplantation. 2005 Oct 15;80(7):883-9. doi: 10.1097/01.tp.0000184006.43152.8d. Transplantation. 2005. PMID: 16249734

10

Post-transplant de novo malignancies in renal transplant recipients: the past and present.

Kauffman HM, Cherikh WS, McBride MA, Cheng Y, Hanto DW. Kauffman HM, et al. Among authors: cherikh ws. Transpl Int. 2006 Aug;19(8):607-20. doi: 10.1111/j.1432-2277.2006.00330.x. Transpl Int. 2006. PMID: 16827677 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters